secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001493152-24-044828
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals enters CFO consulting agreement; $4k/month, 25k shares
---------------------------------------------------------------------

- Consulting agreement with CFO Eugene Johnston effective Oct 1, 2024 for 12 months.
- Cash compensation: $4,000 per month.
- Equity: 25,000 shares of common stock under 2022 Equity Incentive Plan, vested on execution.
- Agreement includes non-solicitation covenants and standard confidentiality.
- Johnston continues as CFO; no change in leadership role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224044828/0001493152-24-044828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224044828/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-044828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer